Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

emra-med arzneimittel gmbh - diclofenac-n-ethylethanamin - gel - diclofenac-n-ethylethanamin 23.2mg

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

glaxosmithkline consumer healthcare gmbh & co. kg (8090037) - diclofenac-n-ethylethanamin - gel - teil 1 - gel; diclofenac-n-ethylethanamin (23930) 11,6 milligramm

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

glaxosmithkline consumer healthcare gmbh & co. kg (8090037) - diclofenac-n-ethylethanamin - gel - teil 1 - gel; diclofenac-n-ethylethanamin (23930) 23,2 milligramm

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

glaxosmithkline consumer healthcare gmbh & co. kg (8090037) - diclofenac-n-ethylethanamin - gel - teil 1 - gel; diclofenac-n-ethylethanamin (23930) 23,2 milligramm

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

novartis farmaceutica s.a. - diclofenaco - comprimido dispersable - 50 mg - diclofenaco 50 mg - diclofenaco

Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

glaxosmithkline sante grand public - diclofénac sodique 140 mg - emplâtre - 140 mg - pour un emplâtre > diclofénac sodique 140 mg - anti-inflammatoires non-stéroïdiens à usage topique - voltarenplast 1%, emplâtre médicamenteux est un médicament qui soulage la douleur. il fait partie de la classe des anti-inflammatoires non stéroïdiens (ains).voltarenplast 1%, emplâtre médicamenteux est utilisé dans le traitement local de courte durée en cas de traumatismes bénins douloureux : foulures, entorses ou contusions.pour application cutanée uniquement.

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

novartis farmaceutica s.a. - diclofenaco sodico - supositorio - 100 mg - diclofenaco sodico 100 mg - diclofenaco

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 50 mg - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; macrogol 8000; purified talc; iron oxide red; colloidal anhydrous silica; iron oxide yellow; lactose monohydrate; magnesium stearate; povidone; titanium dioxide; peg-40 hydrogenated castor oil; hypromellose; sodium starch glycollate; methacrylic acid copolymer; maize starch; simethicone; sorbic acid; steareth-2 - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: macrogol 8000; iron oxide yellow; peg-40 hydrogenated castor oil; acrylates copolymer; maize starch; sodium starch glycollate; purified talc; colloidal anhydrous silica; microcrystalline cellulose; hypromellose; magnesium stearate; povidone; lactose monohydrate; titanium dioxide; simethicone; sorbic acid; steareth-2 - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 50 mg - suppository, moulded - excipient ingredients: hydrogenated coco-glycerides; hard fat - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. short term (up to three days) treatment of post-operative pain in children.